pf-06305591
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01747941)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
SCN10A inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H](C(N)=O)[C@H](N)c1nc2ccc(C(C)(C)C)cc2[nH]1- Mol. weight
- 274.37 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297317 ↗
Also known as
- pf-06305591
- pf-06305591
- pf-06305591
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01812265 | Phase 1 | Jun 1, 2013 | Pfizer |
| NCT01776619 | Phase 1 | Apr 1, 2013 | Pfizer |
| NCT01797796 | Phase 1 | Apr 1, 2013 | Pfizer |
| NCT01747941 | Phase 1 | Nov 1, 2012 | Pfizer |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 4 | 4 | 1 | 2012 |
1 organizations
Page 1 / 1